10x Genomics (TXG) Capital Expenditures Growth (3y) (2021 - 2026)
Powered by 
Analysis
10x Genomics (TXG) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | -6.49% |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | -0.41% |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | -5.23% |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | -7.41% |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | -7.83% |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | -2.61% |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | -13.49% |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | 7.01% |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | 60.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.17% |
| Mar 31, 2026 | -62.66% |
| Dec 31, 2025 | -64.50% |
| Sep 30, 2025 | -73.42% |
| Jun 30, 2025 | -61.30% |
| Mar 31, 2025 | -59.33% |
| Dec 31, 2024 | -53.84% |
| Sep 30, 2024 | -42.28% |
| Jun 30, 2024 | -41.76% |
| Mar 31, 2024 | -57.85% |
| Dec 31, 2023 | -45.52% |
| Sep 30, 2023 | 210.49% |
| Jun 30, 2023 | -28.30% |
| Mar 31, 2023 | 55.99% |
| Dec 31, 2022 | 82.32% |
| Sep 30, 2022 | 38.80% |
| Jun 30, 2022 | 27.47% |
| Mar 31, 2022 | 44.28% |
| Dec 31, 2021 | 125.64% |